
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study
Riedl, Marc A., Aygören-Pürsün, Emel, Baker, James, Farkas, Henriette, Anderson, John, Bernstein, Jonathan A, Bouillet, Laurence, Busse, Paula, Manning, Michael, Magerl, Markus, Gompels, Mark, HuissooLangue:
english
Journal:
Allergy
DOI:
10.1111/all.13466
Date:
April, 2018
Fichier:
PDF, 466 KB
english, 2018